Cancer Conversations™ in RCC: Improving Outcomes With Immunotherapy and Targeted Agents

Improve your knowledge and apply expert insights on current treatment options for RCC from selecting first-line therapy through understanding treatment options after multiple lines of treatment. View a discussion by experts in an on-demand webcast from a live webinar and then download the slides for use in your own presentations.

Share

Program Content

Activities

IO and Targeted Agents in RCC
Cancer Conversations™:
Improving Outcomes With Immunotherapy and Targeted Agents in RCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 01, 2021

Expires: October 31, 2022

<i>EP</i>: IO and Targeted Agents in RCC
ExpressPoints Cancer Conversations™: Improving Outcomes With Immunotherapy and Targeted Agents in RCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 01, 2021

Expires: October 31, 2022

No activities added yet

Faculty

cover img faculity

Rana R. McKay, MD

Associate Professor of Medical Oncology and Urology
Associate Director, Clinical Sciences
Co-Lead, Genitourinary Malignancies Program
Moores Cancer Center
University of California San Diego
La Jolla, California

cover img faculity

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

cover img faculity

Brian I. Rini, MD

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Eisai

Exelixis, Inc.

Merck Sharp & Dohme Corp.